Serial Registration
Copyright Title
Molecular cancer therapeutics
Status
Published
on 15 Sept 2010
Year of Creation
2009
Copyright Claimant
American Association for Cancer Research, Inc
Registration Number
CSN0137048
on 15 Sept 2010Copyright Summary
The U.S. Copyright record (Registration Number: CSN0137048) dated 15 Sept 2010, pertains to an electronic file (eService) titled "Molecular cancer therapeutics" created in 2009. The copyright holder is American Association for Cancer Research, Inc, known for their creative contributions in serial registration. For any inquiries concerning this copyrighted material, kindly reach out to American Association for Cancer Research, Inc.
Application Details
Registration Number
CSN0137048
Registration Date
9/15/2010
Year of Creation
2009
Agency Marc Code
DLC-CO
Record Status
Changed
Corporate Author
American Association for Cancer Research, Inc
Physical Description
print material
ISSN
1535-7163
Notes
Copyright Local Holdings: v. 8, no. 1, Jan09 Claimant: American Association for Cancer Research, Inc Pub. 2009-01-09 Reg. 2009-10-15 TX0006688900v. 8, no. 2, Feb09 Claimant: American Association for Cancer Research, Inc Pub. 2009-02-10 Reg. 2009-10-15 TX0006688900v. 8, no. 3, Mar09 Claimant: American Association for Cancer Research, Inc Pub. 2009-03-13 Reg. 2009-10-15 TX0006688900v. 8, no. 4, Apr09 Claimant: American Association for Cancer Research, Inc (C.O. correspondence) Pub. 2009-04-13 Reg. 2009-10-15 TX0006688901v. 8, no. 5, May09 Claimant: American Association for Cancer Research, Inc (C.O. correspondence) Pub. 2009-05-12 Reg. 2009-10-15 TX0006688901v. 8, no. 6, Jun09 Claimant: American Association for Cancer Research, Inc (C.O. correspondence) Pub. 2009-06-10 Reg. 2009-10-15 TX0006688901v. 8, no. 7, Jul09 Claimant: American Association for Cancer Research, Inc (C.O. correspondence) Pub. 2009-07-13 Reg. 2009-10-15 TX0006688902v. 8, no. 8, Aug09 Claimant: American Association for Cancer Research, Inc (C.O. correspondence) Pub. 2009-08-12 Reg. 2009-10-15 TX0006688902v. 8, no. 9, Sep09 Claimant: American Association for Cancer Research, Inc (C.O. correspondence) Pub. 2009-09-18 Reg. 2009-10-15 TX0006688902v. 8, no. 10, Oct09 Claimant: American Association for Cancer Research, Inc (C.O. correspondence) Pub. 2009-10-13 Reg. 2010-03-04 TX0006704472 diclv. 8, no. 11, Nov09 Claimant: American Association for Cancer Research, Inc (C.O. correspondence) Pub. 2009-11-11 Reg. 2010-03-04 TX0006704472 diclv. 8, no. 12, Dec09 Claimant: American Association for Cancer Research, Inc (C.O. correspondence) Pub. 2009-12-10 Reg. 2010-03-04 TX0006704472 diclv. 9, no. 1, Jan10 Claimant: American Association for Cancer Research, Inc (C.O. correspondence) Pub. 2010-01-11 Reg. 2010-07-20 TX0006774593 diclv. 9, no. 2, Feb10 Claimant: American Association for Cancer Research, Inc (C.O. correspondence) Pub. 2010-02-10 Reg. 2010-07-20 TX0006774593 diclv. 9, no. 3, Mar10 Claimant: American Association for Cancer Research, Inc (C.O. correspondence) Pub. 2010-03-10 Reg. 2010-07-20 TX0006774593 diclv. 9, no. 4, Apr10 Claimant: American Association for Cancer Research, Inc (C.O. correspondence) Pub. 2010-04-08 Reg. 2010-07-20 TX0006774594 diclv. 9, no. 5, May10 Claimant: American Association for Cancer Research, Inc (C.O. correspondence) Pub. 2010-05-10 Reg. 2010-07-20 TX0006774594 diclv. 9, no. 6, Jun10 Claimant: American Association for Cancer Research, Inc (C.O. correspondence) Pub. 2010-06-10 Reg. 2010-07-20 TX0006774594 dicl
© 2024 reserved by Trademarkia
Show terms & conditions
Disclaimer: The information contained in this website is provided for informational purposes only, and should not be construed as legal advice. Although LegalForce RAPC Worldwide P.C., dba Trademarkia P.C., is a law firm (the “Firm”), your use of this website does not establish an attorney-client relationship with the Firm. Such a relationship can only be established after the Firm decides that it is willing and able to accept the engagement after a conflict check and after a written retainer agreement is agreed upon between you and the Firm. Your use of this website is also subject to our Terms of Use and Privacy Policy. ** The entry level subscription is a bundled price which requires a minimum of two billing cycles, or 6 months.